Back to All Events

PS10: Metabolic disorders

Chairs:  R. Block/ C. Damsgaard

10:00-10:15         N. Tejera             438907
Efficacy of n–3 LCPUFAs in Non-Alcoholic Fatty Liver Disease (NAFLD): Data from two rodent studies

10:15-10:30        R. Valenzuela        426172
Molecular mechanisms involved in the reversal of hepatic steatosis (HE) by dietary supplementation with docosahexaenoic acid (DHA) plus hydroxytyrosol (HT) in mice fed a high-fat diet

10:30-10:45           J. Kaplan   447653
Dietary Fatty Acid Composition Drives Obesity-Associated Metabolic Disease

10:45-11:00            H. Fisk       422484
The effect of obesity on adipose tissue fatty acid composition and lipid mediators, and their response to chronic marine omega-3 fatty acid supplementation: The BIOCLAIMS

11:00-11:15            C. Damsgaard        432956
PPARG and APOE polymorphisms modify associations between n-3 LCPUFA and plasma lipid profile and insulin in 8-11 year-old children

11:15-11:30           A. Ibrahim            432686             
Partial replacement of dietary linoleic acid with α- linolenic acid or long chain n-3 polyunsaturated fatty acids prevents fructose-induced metabolic syndrome via attenuating adipose tissue inflammation and oxidative stress